Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains.
Shigella and enterotoxigenic Escherichia coli (ETEC) continue to be important causes of diarrheal disease in infants and young children in developing countries and are major etiologic agents of traveler's diarrhea. Since attenuated strains of Shigella have been developed as live oral vaccines against shigellosis, we have adapted these attenuated Shigella strains to serve as carriers of ETEC antigens, thereby constituting a hybrid vaccine. Since protective immunity against ETEC is largely directed against fimbrial antigens (of which there are multiple antigenic types), we have individually expressed four different ETEC fimbriae, including CFA/I, CS2, CS3, and CS4, using deltaguaBA attenuated Shigella vaccine strain CVD 1204 as a prototype live vector. Following mucosal (intranasal) immunization of guinea pigs, serum IgG and mucosal IgA responses were elicited against each fimbrial type. An additional strain was constructed expressing a detoxified version of the human ETEC variant of heat labile toxin (LThK63). Following mucosal immunization of guinea pigs with a mixed inoculum containing five Shigella strains each expressing a different ETEC antigen, immune responses were observed against each ETEC antigen plus the Shigella vector.
Barry
Eileen M
EM
Center for Vaccine Development, University of Maryland, 685 West Baltimore Street, Baltimore, MD 21201, USA. ebarry@umaryland.edu
Altboum
Zeev
Z
Losonsky
Genevieve
G
Levine
Myron M
MM
D000818:Animals; D001427:Bacterial Toxins / Q000096:biosynthesis* / Q000276:immunology*; D015153:Blotting, Western; D003001:Cloning, Molecular; D004405:Dysentery, Bacillary / Q000276:immunology / Q000517:prevention & control; D004768:Enterotoxins / Q000096:biosynthesis* / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D004926:Escherichia coli / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D029968:Escherichia coli Proteins; D022361:Escherichia coli Vaccines / Q000276:immunology*; D006168:Guinea Pigs; D006385:Hemagglutination Inhibition Tests; D007114:Immunization; D008967:Molecular Biology; D009154:Mutation / Q000276:immunology*; D010957:Plasmids / Q000276:immunology; D012760:Shigella / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D022281:Shigella Vaccines / Q000276:immunology*; D013045:Species Specificity
D001427:Bacterial Toxins; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D022361:Escherichia coli Vaccines; D022281:Shigella Vaccines; C027538:heat-labile enterotoxin, E coli